Case reportProlonged Extracorporeal Membrane Oxygenation and Circulatory Support as Bridge to Lung Transplant
Section snippets
Comment
Prolonged extracorporeal lung assist as a bridge to lung transplantation was successful in this particular case, but the story raises many questions. The worldwide lack of donor organs makes prioritization among the possible recipients crucial. Progressive alveolitis and fibrosis secondary to systemic inflammatory autoimmune disease is an uncommon indication for lung transplantation with variable results [1], although anti-rejection immunosuppressive treatment (including tacrolimus) may be
References (5)
- et al.
International guidelines for the selection of lung transplant candidates: 2006 update—a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation
J Heart Lung Transplant
(2006) - et al.
Artificial lungs: a new inspiration
Perfusion
(2002)
Cited by (55)
Development of an ambulatory extracorporeal membrane oxygenation system: From concept to clinical use
2022, Applications in Engineering ScienceExtracorporeal membrane oxygenation in cardiopulmonary disease of rheumatic conditions: A systematic review
2020, Medicina ClinicaCitation Excerpt :Most patients received glucocorticoids at different dosing regimens to treat disease flares, except when the risk of infection was considered too great. Immunomodulatory therapies used during ECMO included plasmapheresis5,7–9,18–21 plasma exchange,6,22 endovenous immunoglobulins (IVIg),11,17,19,23 conventional disease modifying antirheumatic drugs (cDMARDs)13 and even cytostatic such as cyclophosphamide(CTX)5,7,8,17,18,20,22,24 or tacrolimus.25 During ECMO therapy, in life threatening situations biologic therapy can be considered, with cases of successful CD 20 depletion7,10,25 or interleukin-1 neutralization11 reported.
Recommendations for the treatment of anti-melanoma differentiation-associated gene 5-positive dermatomyositis-associated rapidly progressive interstitial lung disease
2020, Seminars in Arthritis and RheumatismLung Transplant in Patients with Connective Tissue Diseases
2019, Clinics in Chest MedicineCitation Excerpt :Although few studies have explored this in detail, the number of patients with increased PRA levels was similar in SSc and non-SSc groups in 2 studies.39,42 Fewer reports have studied patients with non-SSc CTDs (see Table 1),48–50 although individual case reports have described successful outcomes.14,15,36 One-year, 3-year, and 5-year survival in patients with non-SSc CTDs is similar to survival in patients with IPF or non-CTD ILDs.
Canada's longest experience with extracorporeal membrane oxygenation as a bridge to lung transplantation: A case report
2015, Transplantation ProceedingsExtracorporeal membrane oxygenation in lung transplantation
2013, Medicina Intensiva